As of 3:10pm ET
| +0.05 / +1.14%|
The 5 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 10.00, with a high estimate of 13.00 and a low estimate of 7.00. The median estimate represents a +124.72% increase from the last price of 4.45.
The current consensus among 5 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.